However, addition of the IL15Rα-IL15 fusion protein improved therapeutic efficacy of myxoma virus compared to the other virus controls, including myxoma virus that expressed only the native IL15 domain (Figure 7). The gene discussed is IL15RA; the disease is myxoma.